Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 30S ribosomal subunit decoding A-site is a critical functional region within the bacterial ribosome responsible for ensuring the fidelity of protein synthesis (Ogle et al., 2001). Located primarily within the 16S ribosomal RNA (rRNA), specifically at the decoding center of the small subunit, this site facilitates the accurate pairing between mRNA codons and aminoacyl-tRNA anticodons (Vicens & Westhof, 2003). During translation, the A-site monitors the geometry of the codon-anticodon helix, triggering a conformational change that allows the ribosome to proceed with peptide bond formation. This site is the primary pharmacological target for aminoglycoside antibiotics, which bind with high affinity to the internal loop of helix 44 (Mingeot-Leclercq et al., 1999). By binding here, these drugs stabilize a specific conformation of the decoding site that leads to the misreading of the genetic code and the synthesis of aberrant proteins, ultimately resulting in bacterial cell death (Puglisi et al., 2000). Despite their efficacy against Gram-negative pathogens, drugs targeting this site often carry risks of nephrotoxicity and ototoxicity due to structural similarities between the bacterial A-site and the A-site of mitochondrial ribosomes in humans (Hutchin et al., 1993).
Aminoglycoside antibiotics bind to the A-site of the 16S rRNA within the 30S subunit, specifically at the internal loop of helix 44, stabilizing the flipped-out conformation of adenine residues A1492 and A1493 (Ogle et al., 2001). This conformational change mimics the state of correct codon-anticodon pairing, which leads to the incorporation of incorrect amino acids (mistranslation) and the inhibition of ribosomal translocation, ultimately resulting in bacterial cell death (Vicens & Westhof, 2003).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 30S ribosomal subunit decoding A-site (30S A-site).